SPDR S&P Biotech ETF (NYSEARCA:XBI) is Abundance Wealth Counselors’ 5th Largest Position

Abundance Wealth Counselors increased its position in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 1.8% in the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 184,993 shares of the exchange traded fund’s stock after purchasing an additional 3,215 shares during the period. SPDR S&P Biotech ETF accounts for about 3.6% of Abundance Wealth Counselors’ investment portfolio, making the stock its 5th biggest holding. Abundance Wealth Counselors’ holdings in SPDR S&P Biotech ETF were worth $16,660,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Avior Wealth Management LLC grew its position in shares of SPDR S&P Biotech ETF by 393.6% in the 4th quarter. Avior Wealth Management LLC now owns 385 shares of the exchange traded fund’s stock worth $35,000 after acquiring an additional 307 shares in the last quarter. Tidemark LLC lifted its stake in SPDR S&P Biotech ETF by 101.5% during the third quarter. Tidemark LLC now owns 395 shares of the exchange traded fund’s stock worth $39,000 after purchasing an additional 199 shares during the last quarter. Quintet Private Bank Europe S.A. bought a new stake in SPDR S&P Biotech ETF during the third quarter valued at $40,000. ORG Wealth Partners LLC acquired a new stake in shares of SPDR S&P Biotech ETF during the third quarter worth $44,000. Finally, Howe & Rusling Inc. bought a new position in shares of SPDR S&P Biotech ETF in the 3rd quarter worth about $49,000.

SPDR S&P Biotech ETF Stock Down 0.9 %

Shares of NYSEARCA:XBI opened at $92.67 on Friday. The firm has a 50-day simple moving average of $93.24 and a 200 day simple moving average of $96.72. SPDR S&P Biotech ETF has a fifty-two week low of $81.14 and a fifty-two week high of $105.47. The company has a market cap of $7.06 billion, a PE ratio of 11.47 and a beta of 1.11.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.